Relationship between dose of antithyroid drugs and adverse events in pediatric patients with Graves’ disease

Graves’ disease (GD) accounts for a large proportion of pediatric hyperthyroidism, and the first-line treatment is antithyroid drug (ATD) therapy. Methimazole (MMI) is effective in most patients but is associated with significant adverse events (AEs). We reviewed the medical records of GD patients (...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Clin Pediatr Endocrinol
Hoofdauteurs: Yasuda, Kie, Miyoshi, Yoko, Tachibana, Makiko, Namba, Noriyuki, Miki, Kazunori, Nakata, Yukiko, Takano, Toru, Ozono, Keiichi
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: The Japanese Society for Pediatric Endocrinology 2017
Onderwerpen:
Original Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5295245/
https://ncbi.nlm.nih.gov/pubmed/28203042
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1297/cpe.26.1
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items